Chemical Compound

Saquinavir mesylate

CAS Registry Number 149845-06-7
Saquinavir mesylate chemical structure
Primary Record

Saquinavir mesylate

In stock
1,877 g
Purity
98.5 %
CAS
149845-06-7

Compound Identifiers & Properties

CAS
149845-06-7
PubChem CID
60934
SMILES
CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@H]([C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O.CS(=O)(=O)O
Canonical SMILES
CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1.CS(=O)(=O)O

Names & Synonyms

  • Saquinavir mesylate
  • Invirase
  • Fortovase
  • Saquinavir mesilate
  • 149845-06-7
  • Saquinavir, Mesylate
  • Invirase (TN)
  • Saquinavir (Mesylate)
  • Saquinavir Mesylate?
  • SAQUINAVIR
  • 6-Bromonicotinaldehyde
  • Saquinavir mesilate RS
  • Saquinavir mesylate [USAN]
  • UNII-UHB9Z3841A
  • Saquinavir mesilate CRS
  • SAQUINAVIRMESYLATE
  • RefChem:57421
  • Ro 31-8959/003
  • Saquinavir methanesulfonate salt
  • UHB9Z3841A
  • DTXSID9023835
  • Saquinavir mesilate (JAN)
  • Saquinavir mesylate (USP)
  • Saquinavir monomethanesulfonate salt
  • AC1L1U6R
  • DTXCID803835
  • SCHEMBL42352
  • MLS001401395
  • Saquinavir mesylate [USAN:USP]
  • Saquinavir Monomethanesulfonate
  • IRHXGOXEBNJUSN-YOXDLBRISA-N
  • MFCD00944907
  • CHEMBL282042
  • SCHEMBL29362141
  • SCHEMBL29403886
  • 6-bromopyridine-3-carboxaldehyde
  • C39H54N6O8S
  • CHEBI:32121
  • CTK8E9063
  • Saquinavir mesylate (USAN:USP)
  • AOB1668
  • SAQUINAVIR MESILATE [JAN]
  • C38H50N6O5.CH4O3S
  • Saquinavir (mesylate) (Standard)
  • C38H50N6O5
  • GLXC-02559
  • HMS1571O10
  • HMS2051D04
  • HMS2098O10
  • HMS2231C15
  • HMS3715O10
  • 149845-06-7 (mesylate)
  • Ro-31-8959/003
  • Saquinavir mesylate (AIDS Initiative)
  • SAQUINAVIR MESYLATE [VANDF]
  • CID60934
  • DRG-0164
  • SAQUINAVIR MESILATE (MART.)
  • SAQUINAVIR MESILATE [MART.]
  • Ro-318959003
  • Tox21_111137
  • Tox21_202533
  • HY-17003R
  • LS-872
  • NCGC00091469-01
  • Ro 31-8959
  • SAQUINAVIR MESILATE [WHO-DD]
  • SAQUINAVIR MESILATE [WHO-IP]
  • SAQUINAVIR MESYLATE (USP-RS)
  • SAQUINAVIR MESYLATE [USP-RS]
  • Saquinavir for system suitability CRS
  • AKOS015962362
  • AC-1333
  • ACN-043391
  • CCG-100992
  • EBC-102160
  • FS27793
  • KS-1110
  • NC00242
  • Saquinavir mesylate - Bio-X trade mark
  • NCGC00260082-01
  • Ro-31-8959
  • SAQUINAVIR MESYLATE [ORANGE BOOK]
  • AN-15024
  • BC680513
  • BS164392
  • CPD000469290
  • R-56
  • SAM001246578
  • SAQUINAVIR MESILATE (EP MONOGRAPH)
  • SAQUINAVIR MESILATE [EP MONOGRAPH]
  • SAQUINAVIR MESYLATE (USP IMPURITY)
  • SAQUINAVIR MESYLATE [USP IMPURITY]
  • SMR000469290
  • SAQUINAVIR MESYLATE (USP MONOGRAPH)
  • SAQUINAVIR MESYLATE [USP MONOGRAPH]
  • RT-015634
  • C38-H50-N6-O5.C-H4-O3-S
  • CAS-149845-06-7
  • FT-0631179
  • SAQUINAVIR METHANESULFONATE SALT [MI]
  • Ro-31-8959-003
  • Saquinavir mesylate, >=98% (HPLC), powder
  • A12071
  • C12560
  • D01160
  • F84902
  • W-5240
  • Butanediamide, N1-[(1S,2R)-3-[(3S,4aS,8aS)-3-[[(1,1-dimethylethyl)amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]-, (2S)-, methanesulfonate (1:1)
  • 845S067
  • A884226
  • SR-01000763454
  • (S)-N1-((2S,3R)-4-((3S,4aS,8aS)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl)-3-hydroxy-1-phenylbutan-2-yl)-2-(quinoline-2-carboxamido)succinamide methanesulfonate
  • SR-01000763454-4
  • Q27114794
  • (2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide;methanesulfonic acid
  • B2693-059341
  • (S)-N-((alphaS)-alpha-((1R)-2-((3S,4aS,8aS)-3-(tert-Butylcarbamoyl)octahydro-2(1H)-isoquinolyl)-1-hydroxyethyl)phenethyl)-2-quinaldamidosuccinamide monomethanesulfonate (salt)
  • Butanediamide, N1-((1S,2R)-3-((3S,4aS,8aS)-3-(((1,1-dimethylethyl)amino)carbonyl)octahydro-2(1H)-isoquinolinyl)-2-hydroxy-1-(phenylmethyl)propyl)-2-((2-quinolinylcarbonyl)amino)-, (2S)-, monomethanesulfonate (salt)
  • SQV
  • Saquinavir mesilate, European Pharmacopoeia (EP) Reference Standard
  • (2S)-N1[(1S,2R)-3-[(3S,4aS,8aS)-3-[[(1,1-Dimethylethyl)amino]carbonyl]octahydro-2-(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]butanediamide Mesylate
  • Butanediamide, N(sup 1)-(3-(3-(((1,1-dimethylethyl)amino)carbonyl)octahydro-2(1H)-isoquinolinyl)-2-hydroxy-1-(phenylmethyl)propyl)-2-((2-quinolinylcarbonyl)amino)-, (3S-(2(1R*(R*),2S*),3alpha,4abeta,8abeta))-, monomethanesulfonate (salt)
  • Saquinavir mesylate, United States Pharmacopeia (USP) Reference Standard
  • 2-[[2-METHYL-3-(TRIFLUOROMETHYL)PHENYL]AMINO]PYRIDINE-3-CARBOXYLIC ACID MESYLATE
  • Saquinavir for system suitability, European Pharmacopoeia (EP) Reference Standard
  • (2S)-N-[(1S,2R)-3-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-1-benzyl-2-hydroxy-propyl]-2-(quinoline-2-carbonylamino)butanediamide; methanesulfonic acid
  • (2S)-N-[(1S,2R)-3-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-1-benzyl-2-hydroxy-propyl]-2-(quinoline-2-carbonylamino)butanediamide;methanesulfonic acid
  • (2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide methanesulfonate
  • (2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide; methanesulfonic acid
  • (2S)-N1-[(1S,2R)-3-[(3S,4aS,8aS)-3-[[(1,1-dimethylethyl)amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]butanediamide methanesulfonate
  • (2S)-N1[(1S,2R)-3-[(3S,4aS,8aS)-3-[[(1,1-Dimethylethyl)amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]butanediamide methanesulfonate
  • (S)-N-((.ALPHA.S)-.ALPHA.-((1R)-2-((3S,4AS,8AS)-3-(TERT-BUTYLCARBAMOYL)OCTAHYDRO-2(1H)-ISOQUINOLYL)-1-HYDROXYETHYL)PHENETHYL)-2-QUINALDAMIDOSUCCINAMIDE MONOMETHANESULFONATE
  • (S)-N-((.ALPHA.S)-.ALPHA.-((1R)-2-((3S,4AS,8AS)-3-(TERT-BUTYLCARBAMOYL)OCTAHYDRO-2(1H)-ISOQUINOLYL)-1-HYDROXYETHYL)PHENETHYL)-2-QUINALDAMIDOSUCCINAMIDE MONOMETHANESULPHONATE
  • (S)-N-((alphaS)-alpha-((1R)-2-((3S,4AS,8AS)-3-(TERT-BUTYLCARBAMOYL)OCTAHYDRO-2(1H)-ISOQUINOLYL)-1-HYDROXYETHYL)PHENETHYL)-2-QUINALDAMIDOSUCCINAMIDE MONOMETHANESULFONATE
  • (S)-N-((alphaS)-alpha-((1R)-2-((3S,4AS,8AS)-3-(TERT-BUTYLCARBAMOYL)OCTAHYDRO-2(1H)-ISOQUINOLYL)-1-HYDROXYETHYL)PHENETHYL)-2-QUINALDAMIDOSUCCINAMIDE MONOMETHANESULPHONATE
  • (S)-N-((alphaS)-alpha-((1R)-3S,4aS,8aS)-3-(tert-Butylcarbaoyl)octahydro-2(1H)-isoquinolyl)-1-hydroxyethyl)phenethyl)-2-quinaldamidosuccinam ide monomethanesulfonate (salt)
  • 127779-20-8
  • BUTANEDIAMIDE, N(SUP 1)-(3-(3-(((1,1-DIMETHYLETHYL)AMINO)CARBONYL)OCTAHYDRO-2(1H)-ISOQUINOLINYL)-2-HYDROXY-1-(PHENYLMETHYL)PROPYL)-2-((2-QUINOLINYLCARBONYL)AMINO)-, (3S-(2(1R*(R*),2S*),3.ALPHA.,4A.BETA.,8A.BETA.))-, MONOMETHANESULFONATE
  • BUTANEDIAMIDE, N(SUP 1)-(3-(3-(((1,1-DIMETHYLETHYL)AMINO)CARBONYL)OCTAHYDRO-2(1H)-ISOQUINOLINYL)-2-HYDROXY-1-(PHENYLMETHYL)PROPYL)-2-((2-QUINOLINYLCARBONYL)AMINO)-, (3S-(2(1R*(R*),2S*),3.ALPHA.,4A.BETA.,8A.BETA.))-, MONOMETHANESULPHONATE
  • BUTANEDIAMIDE, N(SUP 1)-(3-(3-(((1,1-DIMETHYLETHYL)AMINO)CARBONYL)OCTAHYDRO-2(1H)-ISOQUINOLINYL)-2-HYDROXY-1-(PHENYLMETHYL)PROPYL)-2-((2-QUINOLINYLCARBONYL)AMINO)-, (3S-(2(1R*(R*),2S*),3alpha,4Abeta,8Abeta))-, MONOMETHANESULFONATE
  • BUTANEDIAMIDE, N(SUP 1)-(3-(3-(((1,1-DIMETHYLETHYL)AMINO)CARBONYL)OCTAHYDRO-2(1H)-ISOQUINOLINYL)-2-HYDROXY-1-(PHENYLMETHYL)PROPYL)-2-((2-QUINOLINYLCARBONYL)AMINO)-, (3S-(2(1R*(R*),2S*),3alpha,4Abeta,8Abeta))-, MONOMETHANESULPHONATE
  • Methanesulfonic acid--N~1~-{(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl]-3-hydroxy-1-phenylbutan-2-yl}-N~2~-(quinoline-2-carbonyl)-L-aspartamide (1/1)
  • N-t-butyl-decahydro-2-[2(R)-hydroxy-4-phenyl-3(S)-[[N-(2-quinolylcarbonyl)-L-asparaginyl]amino]butyl]-(4aS,8aS)-isoquinoline-3(S)-carboxamide methanesulphonate
  • Saquinavir mesilate; (2S)-N1-[(1S,2R)-1-Benzyl-3-[(3S,4aS,8aS)-3-[(1,1-dimethylethyl)carbamoyl]octahydroisoquinolin-2(1H)-yl]-2-hydroxypropyl]-2-[(quinolin-2-ylcarbonyl)amino]butanediamide methanesulfonate; Butanediamide, N1-[(1S,2R)-3-[(3S,4aS,8aS)-3-[[(1,1-dimethylethyl)amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]-, (2S)-, methanesulfonate (1:1); Butanediamide, N1-[(1S,2R)-3-[(3S,4aS,8aS)-3-[[(1,1-dimethylethyl)amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]-, (2S)-, monomethanesulfonate (salt) (9CI); Invirase; Ro 31-8959/003; Saquinavir mesylate; Butanediamide, N1-[3-[3-[[(1,1-dimethylethyl)amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]-, [3S-[2[1R*(R*),2S*],3alpha,4abeta,8abeta]]-, monometha